Ligand validation:3BJY

DCP: 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE

DCP is a Ligand Of Interest in 3BJY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3BJY_DCP_A_739	64%	15%	0.171	0.97	1.92	2.04	5	7	1	0	100%	1
6X6Z_DCP_A_801	96%	13%	0.078	0.987	3.22	0.95	14	1	0	0	100%	1
6X77_DCP_A_804	94%	10%	0.086	0.988	3.18	1.41	13	5	1	0	100%	1
6X71_DCP_P_106	91%	9%	0.082	0.97	3.56	1.14	13	4	0	0	100%	0.688
6X75_DCP_A_804	89%	10%	0.098	0.976	3.48	1.06	13	3	0	0	100%	1
5WM8_DCP_A_804	86%	41%	0.108	0.976	0.79	1.56	1	9	0	0	100%	1
3IAY_DCP_A_986	99%	51%	0.058	0.986	0.9	0.98	1	2	2	0	100%	1
4YR0_DCP_A_501	98%	55%	0.067	0.986	0.83	0.91	1	2	0	0	100%	1
2HVW_DCP_C_1203	97%	53%	0.062	0.977	0.86	0.95	1	1	0	0	100%	1
4RZR_DCP_D_401	97%	48%	0.069	0.984	0.84	1.19	-	3	0	0	100%	1
7RBH_DCP_A_402	97%	57%	0.069	0.983	0.83	0.81	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.